Terra Innovatum Global NV

NKLR · NASDAQ

$2.02−$0.06 (−2.88%)TodayMarket closed · Oct 23, 7:58 PM ET

Prev close $2.08

NKLR analyst rating

BuyConsensus of 3 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy3
Hold0
Underperform0
Sell0

12-month price target · 7 analysts

Average $17.14 (+748.3% upside)

Low: $10.10
Now: $2.02
High: $26.25

Upgrades and downgrades

The latest rating actions, newest first

NKLR analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
HC Wainwright & Co.	Sep 1, 2026	Maintains	Buy	$25.00	16%
HC Wainwright & Co.	Jul 9, 2026	Maintains	Buy	$25.00	16%
Canaccord Genuity	Feb 20, 2026	Initiates	Buy	$10.00	34%
HC Wainwright & Co.	Dec 30, 2025	Initiates	Buy	$25.00	16%
B. Riley Securities	Dec 2, 2025	Initiates	Buy	$10.00	18%

The case for and against

Updated Oct 22, 2026

Bull case

Terra Innovatum Global is fundamentally attractive because its SOLO reactor combines a 1MWe modular design with 24/7 operation for 15 years without refueling, using off-the-shelf components and commercially available LEU to lower technical, regulatory, and supply-chain risk. Its NRC progress, including the initial nine PSAR chapters, the Environmental Report, and targeted completion of the remaining PSAR and construction-permit chapters by October 2026, supports a credible path toward FOAK deployment in 2027 and commercial scale-up in 2028. Financially, the company’s expected $60-70M cash burn over the next 15-18 months and the fact that it has secured over 80% of its BOM suggest disciplined execution, while the projected move from $80M of unit sales in 2029 to much larger revenues later underscores meaningful long-term operating leverage.

Bear case

Terra Innovatum Global is facing a fundamentally challenging investment case because operating costs jumped to $6.1M in 2Q26 from $2.2M a year ago and $6.6M in 1Q26 from $1.4M a year ago, while losses widened to $18.0M in 2Q26 and $7.1M in 1Q26. The company’s cash and marketable securities fell from $96.7M as of March 31, 2026 to $91.1M as of June 30, 2026, yet it still carries no debt, suggesting a balance sheet that is funded but under pressure from rising spend. Its outlook is weighed down by major regulatory, supply chain, technological, execution, dilution, and market adoption risks, and the $12.5M fair value change in contingent liability in 2Q26 underscores how volatile the financial profile remains.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.